Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine

Diabetologia

Volumn 40, Issue 6, 1997, Pages 629-634

  Hammes, H P ^a   Bartmann, A ^b   Engel, L ^b   Wulfroth P ^b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b MERZ PHARMACEUTICALS GMBH   (Germany)

Author keywords

Diabetic retinopathy; Experimental; Nicanartine; Oxidant stress; Rat

Indexed keywords

ANTIOXIDANT; NICANARTINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; GLUCOSE BLOOD LEVEL; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PRIORITY JOURNAL; RAT; STRESS;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ENZYME INDUCTION; GLYCOSYLATION END PRODUCTS, ADVANCED; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HEMOGLOBIN A, GLYCOSYLATED; MALE; NEUROGLIA; PYRIDINES; RATS; RATS, INBRED LEW; RETINA; RETINAL VESSELS;

EID: 0030802526     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050726     Document Type: Article

References (42)

1. DCCT Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986
2. Kador PF, Robison WG, Kinoshita JH (1985) The pharmacology of aldose reductase inhibitors. Ann Rev Pharmacol and Toxicol 25: 691-714
3. Ruderman NN, Williamson JR, Brownlee M (1992) Glucose and diabetic vascular disease. FASEB J 6: 2905-2914
4. Greene DA, Lattimer SA, Sima AAF (1987) Sorbitol, phosphoinositide and the sodium-potassium ATPase in the pathogenesis of diabetic complications. New Engl J Med 316: 599-606
5. Lee TS, Saltsman KA, Ohashi K, King GL (1989) Activation of protein kinase C by elevation of glucose concentration. Proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci USA 86: 5141-5145
6. Brownlee M (1994) Lilly lecture 1993. Glycation and diabetic complications. Diabetes 43: 836-841
7. Wolff SP, Dean RT (1987) Glucose autoxidation and protein modification. The potential role of "autoxidative glycosylation" in diabetes. Biochem J 245: 243-250
8. Mullarkey CJ, Edelstein D, Brownlee M (1990) Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun 173: 932-939
9. Dyer DG, Blackledge JA, Katz BM et al. (1990) The Maillard reaction in vivo. J Nutr Sci 29: 13-20
10. Baynes JW (1991) Perspectives in diabetes. Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412
11. Hicks M, Delbridge L, Yue DK, Reeve TS (1988) Catalysis of lipid peroxidation by glucose and glycosylated collagen. Biochem Biophys Res Commun 151: 649-655
12. Morel DW, Hessler JW, Chisolm GM (1983) Low density lipoprotein cytotoxicity induced by tree radical peroxidation of lipid. J Lipid Res 24: 1070-1076
13. Hessler JR, Robertson Jr AL, Chisolm III GM (1979) LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis 32: 213-229
14. Lyons TJ, Li W, Wells-Knecht MC, Jokl R (1994) Toxicity of mildly modified low-density lipoproteins to cultured retinal capillary endothelial cells and pericytes. Diabetes 43: 1090-1095
15. Watanabe J, Umeda F, Wakasugi H, Ibayashi H (1984) Effect of vitamin E on platelet aggregation in diabetes mellitus. Thromb Haemostas 51: 313-316
16. Uzel N, Sivas A, Uysal M, Oz H (1987) Erythrocyte lipid peroxidation and glutathione peroxidase activities in patients with diabetes mellitus. Horm Met Res 19: 89-90
17. Crouch R, Kimsey G, Priest DG, Sarda A, Buse MG (1978) Effect of streptozotocin on erythrocyte and retinal superoxide dismutase. Diabetologia 15: 53-57
18. Jiang YZ, Towler HMA, Luthert P, Lightman S (1996) Pathophysiology of diabetic retinopathy. In: LeRoith D, Taylor SI, Olefsky JM (eds) Diabetes mellitus. Lippincott-Raven, Philadelphia pp. 719-727
19. Tilton RG, Chang K, Faller AF (1993) Probucol prevents vascular protein leakage induced by diabetes, glucose, and glycated proteins. Diabetes 42 [Suppl 1]:89A (Abstract)
20. Wülfroth PM (1995) Nicanartine. Drug of the Future. 20: 572-574
21. Wülfroth PM, Bartmann A, Hopstock CC, Reichel JE (1995) The new antioxidant MRZ 3/124 improves lipid status and prevents oxidative injury to endothelial cells and macrophages. Bull Mol Biol Med 20: 83-85
22. Wülfroth PM, Bartmann A, Hopstock C, Reichel J, Urien S, Tillement JP (1995) The new antioxidant MRZ 3/124 has a high affinity to lipoproteins and cells of the vascular wall thereby protecting against damage induced by reactive oxygen species. In: Jaross W et al. (eds) 1995 Advances in lipoproteins and atherosclerosis research, diagnostic and treatment. Jena, Stuttgart, New York, pp. 258-261
23. Esterbauer H, Striegl G, Puhl H, Rotheneder M (1989) Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Comm 6: 67-75
24. Hammes HP, Martin S, Federlin K, Geisen K, Brownlee M (1991) Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci USA 88: 11555-11558
25. Monnier VM, Kohn RR, Cerami A (1984) Accelerated age-related browning of human collagen in diabetes mellitus. Proc Natl Acad Sci USA 81: 583-587
26. Odetti P, Pronzato MA, Noberasco G et al. (1994) Relationship between glycation and oxidation related fluorescences in rat collagen during aging. An in vivo and in vitro study. Lab Invest 70: 61-67
27. Maines MD, Trakshel GM, Kutty RK (1986) Characterization of two constitutive forms of rat liver heme oxygenase; only one form is induced. J Biol Chem 261: 411-419
28. Yan SD, Schmidt AM, Anderson GM et al. (1994) Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 269: 9889-9897
29. Stocker R (1990) Induction of haem oxygenase as a defence against oxidative stress. Free Radical Res Commun 9: 101-112
30. Schwartzman ML, Masferrer J, Dunn MW, McGiff JC, Abraham NG (1987) Cytochrome P450, drug metabolizing enzymes and arachidonic acid metabolism in bovine ocular tissues. Curr Eye Res 6: 623-630
31. Kutty RK, Kutty G, Wiggert B, Chader GJ, Darrow RM, Organisciak DT (1995) Induction of heme oxygenase 1 in the retina by intense visible light: suppression by the antioxidant dimethylthiourea. Proc Natl Acad Sci 92: 1177-1181
32. Kowluru RA, Kern TS, Engerman RL, Armstrong D (1996) Abnormalities of retinal metabolism in diabetes or experimental galactosemia. Effects of antioxidants. Diabetes 45: 1233-1237
33. Soulis-Liparota T, Cooper ME, Dunlop M, Jerums G (1995) The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley rat. Diabetologia 38: 387-394
34. Parinandi NI, Thompson EW, Schmid HH (1990) Diabetic heart and kidney exhibit increased resistance to lipid peroxidation. Biochim Biophys Acta 1047: 63-69
35. Oster MH, Llobet JM, Domingo JL, German JB, Keen C (1993) Vanadium treatment of diabetic Sprague-Dawley rats results in tissue vanadium accumulation and pro-oxidant effects. Toxicology 83: 115-130
36. Armstrong D, al Awadi F (1991) Lipid peroxidation and retinopathy in streptozotocin-induced diabetes. Free Radic Biol Med 11: 433-436
37. Kern TS, Kowluru RA, Engerman R (1996) Effects of antioxidants on the development of retinopathy in diabetes and galactosemia. Invest Ophthalmol Vis Sci 37/3:S970
38. Hammes HP, Weiss A, Führer D, Kramer HJ, Papavassilis C, Grimminger F (1996) Acceleration of experimental diabetic retinopathy by omega-3 fatty acids. Diabetologia 39: 251-255
39. Cameron NE, Cotter MA, Archibald V, Dines KC, Maxfield EK (1994) Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneural blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats. Diabetologia 37: 449-459
40. Hammes HP, Walter B, Weiss A, Federlin K (1996) Oxidativer Stress bei diabetischer Retinopathie: eine experimentelle Untersuchung. Diabetes & Stoffwechsel 5: 136A
41. Mamo JC, Elsegood CL, Umeda Y, Hirano T, Redgrave TG (1993) Effect of probucol on plasma clearance and organ uptake of chylomicrons and VLDLs in normal and diabetic rats. Arterioscler Thromb 13: 231-239
42. Babiy AV, Gebicki JM, Sullivan DR, Willey K (1992) Increased oxidizability of plasma lipoproteins in diabetic patients can be decreased by probucol therapy and is not due to glycation. Biochem Pharmacol 43: 995-1000